The global Neurorehabilitation Devices Market Growth Accelerated by Increasing Incidences of Neurological Disorders.


 Neurorehabilitation devices aids in restoring motor skills and correcting impaired cognitive functions among patients suffering from neurological disorders such as stroke, Parkinson's disease, spinal cord injury, and traumatic brain injury. Devices such as functional electrical stimulation, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation help regain motor control by reorganizing and reinforcing neural pathways.

The global Neurorehabilitation Devices Market is estimated to be valued at US$ 1.48 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing incidences of neurological disorders has been a key growth driver for the neurorehabilitation devices market. Neurological disorders affect millions of individuals worldwide and are one of the leading causes of death and disability. According to the World Health Organization, every year 15 million people suffer from stroke worldwide. Stroke is a major cause of long-term disability. Neurorehabilitation devices help such patients regain motor functionality and improve cognitive abilities. Thus, rising prevalence of neurological conditions has accelerated the demand for neurorehabilitation devices over the recent past and this trend is expected to continue in the foreseeable future.


Segment Analysis

The global neurorehabilitation devices market is dominated by neurorobotic systems segment. Neurorobotic systems aid in gait and motor training for stroke patients through robotic exoskeletons and end-effectors. The devices provide repetitive movements and interactive training through automation. This reduces the manual effort required by therapists and patients can undergo longer training sessions.

Key Takeaways

The global neurorehabilitation devices market is expected to witness high growth over the forecast period of 2023 to 2030. Rapid increase in incidence of neurological disorders such as stroke, spinal cord injury, Parkinson's disease among others is expected to drive the demand for neurorehabilitation devices. The global Neurorehabilitation Devices Market is estimated to be valued at US$ 1.48 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030.

Regional analysis

North America is currently the dominant region in the neurorehabilitation devices market owing to availability of advanced healthcare facilities, favorable reimbursement policies, raising healthcare expenditures and presence of key players. However, Asia Pacific is expected grow at the fastest pace due to rapidly aging population, increasing incidences of neurological disorders, rising healthcare spending and growing medical tourism.

Key players

Key players operating in the neurorehabilitation devices market are Neofect, Boston Scientific Corporation, AlterG Inc., Eodyne, Medtronic plc, Biometrics Ltd., Bioness Inc., Kinestica, Hocoma AG, BIONIK Laboratories Corp., Ekso Bionics Holdings Inc., Abbott Laboratories.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more